The pharmaceutical industry has developed a “hidden web of policy influence” over members of the U.K. parliament through payments that run the risk of creating of “institutional corruption,” according to a new analysis.
Specifically, researchers focused on All-Party Parliamentary Groups, which are informal clusters of lawmakers that focus on particular issues and seek to influence government through meetings and reports (read more here). However, APPGs do not receive government funding, so the findings raise questions about the extent to which these groups act independently.
Create a display name to comment
This name will appear with your comment